The 10-day moving average for OCGN crossed bearishly below the 50-day moving average on July 30, 2024. This indicates that the trend has shifted lower and could be considered a sell signal. In of 17 past instances when the 10-day crossed below the 50-day, the stock continued to move higher over the following month. The odds of a continued downward trend are .
a company, which engages in the development and commercialization of therapies for eye diseases
Industry Biotechnology